title: The association between previous statin use and development of atrial fibrillation in patients presenting with acute coronary syndrome.
abstract: OBJECTIVE
  To examine the association between statin use and the development of atrial fibrillation (AF) in patients presenting with acute coronary syndrome (ACS).
  
  
  METHODS
  From a total of 1000 patients presenting with ACS 241 were on and 759 were not on statin. An AF episode was accepted as endpoint.
  
  
  RESULTS
  The incidence of AF was less frequent in statin group compared to non-statin group (5% vs 10%, respectively, p=0.01). Independent predictors of AF were left atrial diameter, use of statin, age, hypertension, previous AF and use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
  
  
  CONCLUSIONS
  In ACS patients, statin treatment was associated with lower incidence of AF.
authors.affiliation: Department of Cardiology, School of Medicine, Suleyman Demirel University, Isparta, Turkey. mehmetozaydin@hotmail.com
authors.forename: Mehmet
authors.initials: M
authors.lastname: Ozaydin
authors.forename: Yasin
authors.initials: Y
authors.lastname: Turker
authors.forename: Dogan
authors.initials: D
authors.lastname: Erdogan
authors.forename: Mustafa
authors.initials: M
authors.lastname: Karabacak
authors.forename: Abdullah
authors.initials: A
authors.lastname: Dogan
authors.forename: Ercan
authors.initials: E
authors.lastname: Varol
authors.forename: Emel
authors.initials: E
authors.lastname: Gonul
authors.forename: Ahmet
authors.initials: A
authors.lastname: Altinbas
mesh_terms: D054058:Acute Coronary Syndrome / Q000453:epidemiology*; D000367:Age Factors; D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000453:epidemiology*; D005260:Female; D006325:Heart Atria / Q000000981:diagnostic imaging; D006333:Heart Failure / Q000453:epidemiology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006973:Hypertension / Q000453:epidemiology; D015994:Incidence; D008297:Male; D008875:Middle Aged; D013318:Stroke Volume; D014463:Ultrasonography
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors